Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Archetype and rearranged non-coding control regions (NCCR) in urothelial bladder carcinoma of immunocompetent individuals CANCER GENOMICS & PROTEOMICS 2016
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy THE JOURNAL OF HOSPITAL INFECTION 2016
Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease? ANTIVIRAL THERAPY 2016
Abstracts of ICI 2016 International Congress of Immunology, 21-26 August 2016, Melbourne, Australia EUROPEAN JOURNAL OF IMMUNOLOGY 2016
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice PLOS ONE 2016
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort PLOS ONE 2016
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2016
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort CLINICAL MICROBIOLOGY AND INFECTION 2016
HCV-related diabetes: Still looking for a definition CLINICAL MICROBIOLOGY AND INFECTION 2016
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2016
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients PLOS ONE 2016
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 2016
Cardiovascular risk in HIV-positive subjects: analyses of T-cell phenotype and CD49d expression JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 2016
In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype Assignment JOURNAL OF HEPATOLOGY 2016
HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg JOURNAL OF HEPATOLOGY 2016
Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study JOURNAL OF HEPATOLOGY 2016
Dasabuvir and Ombitasvir/Paritaprevir/Ritonavir with or without Ribavirin in Patients with HIV-HCV Coinfection. Real Life Interim Analysis of an Italian Multicentre Compassionate Use Program JOURNAL OF HEPATOLOGY 2016
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV CLINICAL MICROBIOLOGY AND INFECTION 2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study THE LANCET. HIV 2016
Medical Device: Pre- and Postimplant Testing .13.3.7.1 In Section: Epidemiology and Infection Control Microbiology - IV Edition Clinical Microbiology Procedures Handbook, Medical Devices: Pre- and PostImplant Testing Section 13 "Epidemiologic and Infection Control Microbiology, IV Edition Clinical Microbiology Procedures Handbook 2016

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma